BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28248855)

  • 1. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis.
    Han X; Duan M; Hu L; Zhou D; Zhang W
    Medicine (Baltimore); 2017 Mar; 96(9):e5981. PubMed ID: 28248855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].
    Han X; Hu LX; Ouyang MQ; Duan MH; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):290-294. PubMed ID: 28468089
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
    Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
    Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
    Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
    Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
    Meer S; Perner Y; McAlpine ED; Willem P
    Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
    Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
    Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
    J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and survival analysis of 15 cases of HIV-negative plasmablastic lymphoma].
    Fu WJ; He MX; Huang AJ; Gao L; Lu GH; Chen J; Chen L; Ni X; Zhang WP; Wang JM; Yang JM
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):456-461. PubMed ID: 32654457
    [No Abstract]   [Full Text] [Related]  

  • 10. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
    Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
    Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
    Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N
    Blood; 2024 Jan; 143(2):152-165. PubMed ID: 37832030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
    Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
    Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
    Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
    BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India.
    Rudresha AH; Lakshmaiah KC; Agarwal A; Babu KG; Loknatha D; Jacob LA; Babu S; Lokesh KN; Rajeev LK
    South Asian J Cancer; 2017; 6(2):69-71. PubMed ID: 28702410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmablastic lymphoma].
    Fernández-Álvarez R; Sancho JM; Ribera JM
    Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
    Bibas M
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
    Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
    Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer.
    Bricman L; Yengue P; Miscu C; Junius S; Waignein F; Vandenbulcke JM
    Acta Gastroenterol Belg; 2021; 84(4):663-665. PubMed ID: 34965049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.